| Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy | 2021-06-28 | 2023-05-22 | |
| Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia | 2018-03-13 | 2023-04-13 | 2024-03-13 |
| Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis | 2021-07-12 | 2023-02-15 | 2024-02-12 |
| A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat | 2021-07-30 | 2023-01-04 | 2023-12-20 |
| Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin Lymphoma | 2020-11-15 | 2022-12-20 | |
| COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers | 2021-04-29 | 2022-11-21 | |
| Pozelimab and Cemdisiran Combination Treatment in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Received Pozelimab Monotherapy | 2021-07-29 | 2022-10-25 | |
| A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT) | 2021-04-14 | 2022-08-31 | 2023-08-28 |
| Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity | 2019-10-30 | 2022-08-18 | 2023-04-25 |
| Open-label Study of Dupilumab in Patients With Atopic Dermatitis | 2013-10-10 | 2022-06-27 | 2023-06-23 |
| Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE) | 2020-09-01 | 2022-06-02 | |
| COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age | 2021-09-13 | 2022-06-01 | 2023-01-11 |
| Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease | 2020-06-29 | 2022-05-30 | 2023-07-25 |
| A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults | 2021-10-25 | 2022-05-18 | 2023-05-16 |
| Pozelimab and Cemdisiran Combination Therapy in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Switch From Eculizumab Therapy | 2021-07-08 | 2022-05-05 | |
| REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate Its Long Term Safety, Efficacy and Tolerability. | 2019-12-03 | 2022-04-07 | 2023-04-04 |
| Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP) | 2021-10-13 | 2022-03-01 | |
| Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia | 2020-06-29 | 2022-01-31 | 2023-04-19 |
| Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 | 2020-06-16 | 2022-01-21 | 2023-01-20 |
| Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy | 2020-01-07 | 2022-01-05 | |
| Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma | 2020-03-10 | 2021-12-01 | 2022-11-30 |
| Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease) | 2020-01-27 | 2021-11-09 | 2023-09-15 |
| A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer | 2018-05-29 | 2021-10-27 | 2022-10-10 |
| COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay | 2020-07-13 | 2021-10-04 | 2022-09-29 |
| Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) | 2018-09-24 | 2021-09-09 | 2022-09-04 |
| Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis | 2021-01-14 | 2021-08-24 | 2022-08-22 |
| REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer | 2018-07-02 | 2021-07-29 | 2022-07-28 |
| Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL) | 2017-11-30 | 2021-07-08 | 2022-06-14 |
| PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy | 2017-06-29 | 2021-05-20 | 2022-05-17 |
| Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration | 2019-11-04 | 2021-05-14 | 2023-07-21 |
| Study of Cemiplimab in Adults With Cervical Cancer | 2017-09-05 | 2021-03-15 | 2022-03-11 |
| COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection | 2020-12-15 | 2021-03-04 | 2022-03-03 |
| Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy | 2019-03-12 | 2021-02-19 | 2022-02-16 |
| Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy) | 2018-10-03 | 2020-10-16 | 2023-10-13 |
| Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip | 2019-04-08 | 2020-08-25 | 2023-08-15 |
| Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe | 2018-12-19 | 2020-08-19 | 2021-08-18 |
| Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 | 2020-03-18 | 2020-07-24 | 2021-07-23 |
| Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia | 2017-11-10 | 2020-05-22 | 2022-12-19 |
| A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee | 2019-05-21 | 2020-05-01 | 2021-04-28 |
| Long Term Safety Study of PRALUENT | 2018-09-28 | 2020-04-08 | 2021-04-06 |
| Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis | 2018-11-12 | 2020-03-13 | 2021-10-01 |
| Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis | 2018-11-13 | 2020-03-13 | 2021-12-15 |
| Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo | 2016-11-02 | 2020-03-05 | 2021-03-02 |
| Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee | 2018-10-15 | 2020-01-30 | 2023-01-24 |
| Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge | 2019-02-12 | 2019-12-21 | 2021-04-28 |
| Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis | 2018-06-07 | 2019-12-17 | 2022-12-13 |
| Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip | 2017-10-26 | 2019-12-13 | 2022-12-09 |
| Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH) | 2017-10-03 | 2019-09-27 | 2021-04-23 |
| A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva | 2018-02-26 | 2019-09-16 | 2022-09-15 |
| A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip | 2017-08-17 | 2019-09-09 | 2022-08-25 |